jump to navigation

jump to content

to top of page

BENEO download searchIf you are looking for press releases, images, etc. to download, please use our download search
Search for downloads
Follow us on:

Consumer Insights Confirm that BENEO’s Palatinose™ Meets Consumer Demands for an Alternative Carbohydrate

U.S. consumers recognize that not all carbohydrates are alike. In a recent survey¹ that was conducted on behalf of BENEO, it was shown that consumers differ in their perspectives between various kinds of carbohydrates and are aware of alternative sugars. In fact, half of U.S. consumers believe carbohydrates that are more slowly released are better for health.
The representative quantitative survey with more than 1,000 participants across the U.S. was conducted by the market research company, Wizer. It revealed that half of U.S. females and one third of U.S. males are concerned about tiredness and lack of energy, particularly in the 18 – 44 age group. So, it is not a surprise that almost two-thirds of the U.S. consumers responding to the survey, are (highly) interested in purchasing or consuming a food/drink product providing sustained energy. The insights show that for a similar number of the participants the ideal carbohydrate “delivers energy, is made from a natural source and avoids sugar crashes.”
Jon Peters, President BENEO Inc. summarizes the results: “The survey results show once again that BENEO’s Palatinose™ meets consumer requirements for a new, high quality carbohydrate. The search for sugar alternatives is compatible with consumers’ continuing interest in staying healthy and active. With carbohydrates being the body’s – and the brain’s – main source of fuel, carbohydrates should be chosen wisely with preference to those products with a low impact on blood sugar and insulin levels.”
In contrast to commonly promoted energy ingredients like caffeine or guarana, which may act as stimulants to increase alertness by impacting the central nervous system, Palatinose™ (generic name isomaltulose) induces a low and steady blood glucose response, which delivers a more balanced supply of energy in the form of glucose and contributes to fat burning. Derived from sugar beet, and also naturally occurring in honey, BENEO’s alternative carbohydrate Palatinose™, is generally recognized as safe (GRAS).
As an alternative sugar, BENEO’s Palatinose™ is metabolized in a more gradual way than commonly known sugars such as sucrose. It resembles sucrose molecularly, but it is slowly digested, absorbed and metabolized. This confers numerous metabolic benefits that are not seen with sucrose consumption: causing a slower and lower rise of blood glucose and insulin levels, while providing the needed energy in a sustained and well balanced way². This benefit cannot be underestimated as one-third of the respondents in the current survey indicated they avoid common sugar over concerns about blood sugar levels. Also, more than half of the consumers in the U. S. are concerned about maintaining or losing weight. Palatinose™ offers solutions here as well. Leading to low blood sugar responses and correspondingly low insulin profiles, Palatinose™ contributes to improved fat burning in energy metabolism. Hence it is providing longer-term benefits for blood glucose control, body composition and weight management. As an added advantage and clear difference to commonly known sugars, Palatinose™ has an FDA health claim that it does not cause dental cavities.
Following the validation of high consumer interest in alternative carbohydrates, BENEO will be showcasing “Healthier Carbohydrates, Healthier Living” at this year’s virtual IFT Global Annual Meeting mid-July. In addition to Palatinose™, BENEO will also highlight how prebiotic fibers, plant-based proteins and rice ingredients improve a product’s nutritional profile as well as its taste and texture. This results in foods and beverages which support a more balanced diet, leading to a healthier long-term lifestyle.
¹ Wizer "BENEO Consumer Research on Functional Carbohydrates" in USA 2019
² Maresch, C.C., Petry, S.F., Theis, S., Bosy-Westphal, A., Linn, T. (2017) Low glycemic index prototype isomaltulose - update of clinical trials. Nutrients 9, 381.

Related documents

You can download the press release as .doc (DOCX, 49.99 KB) and .pdf (PDF, 377.97 KB)

Related pictures

Please download the picture here. (JPEG, 70.23 KB)

to top of page


For further information please contact

PR agency contact:
Jo Kent at Publicasity
Tel: +44 1442 261199
Email: BENEO@publicasity.co.uk
BENEO contact:
Thomas Schmidt
Marketing Director
+49 621 421-151
Send me an E-Mail